What is PulseVet?
PulseVet specializes in high-energy focused sound wave therapy systems for animals, offering non-invasive and non-surgical treatments designed to alleviate pain, reduce inflammation, and accelerate healing in horses, cats, and dogs. Their product portfolio includes the core PulseVet device, X-Trode handpieces, and Equine Trode Sets, all engineered for diverse therapeutic applications. The company has earned recognition as a frontrunner in veterinary shock wave technology, supported by extensive peer-reviewed clinical research. PulseVet's mission is to empower veterinarians with effective care solutions, thereby enhancing patient outcomes and client satisfaction.
How much funding has PulseVet raised?
PulseVet has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for PulseVet?
With its recent strategic investment, PulseVet is poised for accelerated growth and further innovation in the veterinary therapeutics market. The substantial capital infusion is expected to fuel the expansion of its product development initiatives, enhance its market reach, and potentially explore new applications for its shock wave technology. This late-stage funding suggests a focus on scaling operations and solidifying its leadership position, likely through increased sales, marketing efforts, and strategic partnerships within the animal health ecosystem. The company's commitment to research and development, coupled with its proven therapeutic solutions, positions it for continued success and impact in improving animal well-being.
See full PulseVet company page
